PRNewsWire
17 Jan 2026, 16:48 UTC · 35w ago
Verdict
Headline leans bearish. We score QURE −1.00.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud investigation after the FDA questioned data for its AMT-130 therapy, leading to a stock price drop of over 50%.
More negative than 75% of ticker scores this week
The company is mentioned as the subject of a securities litigation investigation by a law firm.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Read next
PRNewsWire · 2h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
18h ago
+67.8%
Price is moving against the score
$38.32 vs $22.84 close before publication (Jan 16) · not market-adjusted
QURE chart →
